Literature DB >> 24849368

Regulating Set-β's Subcellular Localization Toggles Its Function between Inhibiting and Promoting Axon Growth and Regeneration.

Ephraim F Trakhtenberg1, Yan Wang2, Melina I Morkin2, Stephanie G Fernandez3, Gregory M Mlacker3, Jesse M Shechter3, Xiongfei Liu3, Karan H Patel3, Allison Lapins3, Steven Yang3, Susan M Dombrowski4, Jeffrey L Goldberg5.   

Abstract

The failure of the CNS neurons to regenerate axons after injury or stroke is a major clinical problem. Transcriptional regulators like Set-β are well positioned to regulate intrinsic axon regeneration capacity, which declines developmentally in maturing CNS neurons. Set-β also functions at cellular membranes and its subcellular localization is disrupted in Alzheimer's disease, but many of its biological mechanisms have not been explored in neurons. We found that Set-β was upregulated postnatally in CNS neurons, and was primarily localized to the nucleus but was also detected in the cytoplasm and adjacent to the plasma membrane. Remarkably, nuclear Set-β suppressed, whereas Set-β localized to cytoplasmic membranes promoted neurite growth in rodent retinal ganglion cells and hippocampal neurons. Mimicking serine 9 phosphorylation, as found in Alzheimer's disease brains, delayed nuclear import and furthermore blocked the ability of nuclear Set-β to suppress neurite growth. We also present data on gene regulation and protein binding partner recruitment by Set-β in primary neurons, raising the hypothesis that nuclear Set-β may preferentially regulate gene expression whereas Set-β at cytoplasmic membranes may regulate unique cofactors, including PP2A, which we show also regulates axon growth in vitro. Finally, increasing recruitment of Set-β to cellular membranes promoted adult rat optic nerve axon regeneration after injury in vivo. Thus, Set-β differentially regulates axon growth and regeneration depending on subcellular localization and phosphorylation.
Copyright © 2014 the authors 0270-6474/14/347361-14$15.00/0.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24849368      PMCID: PMC4028506          DOI: 10.1523/JNEUROSCI.3658-13.2014

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  73 in total

1.  Functional interaction of the DNA-binding transcription factor Sp1 through its DNA-binding domain with the histone chaperone TAF-I.

Authors:  Toru Suzuki; Shinsuke Muto; Saku Miyamoto; Kenichi Aizawa; Masami Horikoshi; Ryozo Nagai
Journal:  J Biol Chem       Date:  2003-05-19       Impact factor: 5.157

2.  The histone chaperone TAF-I/SET/INHAT is required for transcription in vitro of chromatin templates.

Authors:  Matthew J Gamble; Hediye Erdjument-Bromage; Paul Tempst; Leonard P Freedman; Robert P Fisher
Journal:  Mol Cell Biol       Date:  2005-01       Impact factor: 4.272

Review 3.  Retinal axon growth at the optic chiasm: to cross or not to cross.

Authors:  Timothy J Petros; Alexandra Rebsam; Carol A Mason
Journal:  Annu Rev Neurosci       Date:  2008       Impact factor: 12.449

4.  Neurotrophic effect of a novel TrkB agonist on retinal ganglion cells.

Authors:  Ying Hu; Seongeun Cho; Jeffrey L Goldberg
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-10-29       Impact factor: 4.799

5.  Purification and characterization of two putative HLA class II associated proteins: PHAPI and PHAPII.

Authors:  M Vaesen; S Barnikol-Watanabe; H Götz; L A Awni; T Cole; B Zimmermann; H D Kratzin; N Hilschmann
Journal:  Biol Chem Hoppe Seyler       Date:  1994-02

6.  Functional domains of template-activating factor-I as a protein phosphatase 2A inhibitor.

Authors:  S Saito; M Miyaji-Yamaguchi; T Shimoyama; K Nagata
Journal:  Biochem Biophys Res Commun       Date:  1999-06-07       Impact factor: 3.575

7.  The transcription factor serum response factor stimulates axon regeneration through cytoplasmic localization and cofilin interaction.

Authors:  Sina Stern; Stephanie Haverkamp; Daniela Sinske; Andrea Tedeschi; Ulrike Naumann; Simone Di Giovanni; Stefan Kochanek; Alfred Nordheim; Bernd Knöll
Journal:  J Neurosci       Date:  2013-11-27       Impact factor: 6.167

8.  Ser9 phosphorylation causes cytoplasmic detention of I2PP2A/SET in Alzheimer disease.

Authors:  Guang Yu; Tonghai Yan; Ye Feng; Xinghua Liu; Yiyuan Xia; Hongbin Luo; Jian-Zhi Wang; Xiaochuan Wang
Journal:  Neurobiol Aging       Date:  2013-01-29       Impact factor: 4.673

9.  Cytoplasmic p21(Cip1/WAF1) enhances axonal regeneration and functional recovery after spinal cord injury in rats.

Authors:  H Tanaka; T Yamashita; K Yachi; T Fujiwara; H Yoshikawa; M Tohyama
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

10.  RAI1 transcription factor activity is impaired in mutants associated with Smith-Magenis Syndrome.

Authors:  Paulina Carmona-Mora; Cesar P Canales; Lei Cao; Irene C Perez; Anand K Srivastava; Juan I Young; Katherina Walz
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

View more
  13 in total

Review 1.  Molecular and Cellular Mechanisms of Axonal Regeneration After Spinal Cord Injury.

Authors:  Erna A van Niekerk; Mark H Tuszynski; Paul Lu; Jennifer N Dulin
Journal:  Mol Cell Proteomics       Date:  2015-12-22       Impact factor: 5.911

2.  The N-terminal Set-β Protein Isoform Induces Neuronal Death.

Authors:  Ephraim F Trakhtenberg; Melina I Morkin; Karan H Patel; Stephanie G Fernandez; Alan Sang; Peter Shaw; Xiongfei Liu; Yan Wang; Gregory M Mlacker; Han Gao; Dmitry Velmeshev; Susan M Dombrowski; Michael P Vitek; Jeffrey L Goldberg
Journal:  J Biol Chem       Date:  2015-04-01       Impact factor: 5.157

3.  PROTOCADHERIN 7 Acts through SET and PP2A to Potentiate MAPK Signaling by EGFR and KRAS during Lung Tumorigenesis.

Authors:  Xiaorong Zhou; Barrett L Updegraff; Yabin Guo; Michael Peyton; Luc Girard; Jill E Larsen; Xian-Jin Xie; Yunyun Zhou; Tae Hyun Hwang; Yang Xie; Jaime Rodriguez-Canales; Pamela Villalobos; Carmen Behrens; Ignacio I Wistuba; John D Minna; Kathryn A O'Donnell
Journal:  Cancer Res       Date:  2016-11-07       Impact factor: 12.701

4.  KLF9 and JNK3 Interact to Suppress Axon Regeneration in the Adult CNS.

Authors:  Akintomide Apara; Joana Galvao; Yan Wang; Murray Blackmore; Allison Trillo; Keiichiro Iwao; Dale P Brown; Kimberly A Fernandes; Abigail Huang; Tu Nguyen; Masoumeh Ashouri; Xiong Zhang; Peter X Shaw; Noelia J Kunzevitzky; Darcie L Moore; Richard T Libby; Jeffrey L Goldberg
Journal:  J Neurosci       Date:  2017-09-04       Impact factor: 6.167

5.  Promoting filopodial elongation in neurons by membrane-bound magnetic nanoparticles.

Authors:  Wolfgang Pita-Thomas; Michael B Steketee; Stavros N Moysidis; Kinjal Thakor; Blake Hampton; Jeffrey L Goldberg
Journal:  Nanomedicine       Date:  2015-01-14       Impact factor: 5.307

6.  Soluble Amyloid Precursor Protein Alpha Interacts with alpha3-Na, K-ATPAse to Induce Axonal Outgrowth but Not Neuroprotection: Evidence for Distinct Mechanisms Underlying these Properties.

Authors:  Emilie Dorard; Stéphanie Chasseigneaux; Lucie Gorisse-Hussonnois; Cédric Broussard; Thierry Pillot; Bernadette Allinquant
Journal:  Mol Neurobiol       Date:  2017-10-05       Impact factor: 5.590

7.  Optic nerve regeneration in the mouse is a complex trait modulated by genetic background.

Authors:  Jiaxing Wang; Ying Li; Rebecca King; Felix L Struebing; Eldon E Geisert
Journal:  Mol Vis       Date:  2018-02-15       Impact factor: 2.367

8.  The extent of extra-axonal tissue damage determines the levels of CSPG upregulation and the success of experimental axon regeneration in the CNS.

Authors:  Juhwan Kim; Muhammad S Sajid; Ephraim F Trakhtenberg
Journal:  Sci Rep       Date:  2018-06-29       Impact factor: 4.379

Review 9.  What makes a RAG regeneration associated?

Authors:  Thong C Ma; Dianna E Willis
Journal:  Front Mol Neurosci       Date:  2015-08-07       Impact factor: 5.639

10.  Cell types differ in global coordination of splicing and proportion of highly expressed genes.

Authors:  Ephraim F Trakhtenberg; Nam Pho; Kristina M Holton; Thomas W Chittenden; Jeffrey L Goldberg; Lingsheng Dong
Journal:  Sci Rep       Date:  2016-08-31       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.